Castle Biosciences, Inc. CSTL
35.75 USD +0.61 (+1.74%)
At closeNov 4, 2026, 4:26 PM EST
35.75 0.00 0.00%
After hours · Nov 4, 4:26 PM ET
35.07 Day range 36.43
17.72 52-week range 44.28
- YTD
- -8.10%
- 1 year
- +13.03%
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 46.70 +30.6% upside
Now 35.75
- Target (low)
- 35.00
- Target (mean)
- 46.70
- Target (high)
- 60.00
Ratings (0m) 10 10 buy · 0 hold · 0 sell
- Strong buy0
- Buy10
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 10
- 1 month ago 9
- 2 months ago 9
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.346 | -0.42 – -0.25 | -0.02 | -1630.0% | 92.91M | +11.9% | 10 |
| Next quarter | -0.347 | -0.45 – -0.25 | -0.08 | -333.8% | 94.82M | +9.0% | 10 |
| Current year | -1.25 | -1.38 – -1.06 | -0.83 | -50.0% | 374.12M | +8.7% | 10 |
| Next year | -0.935 | -1.56 – -0.43 | -1.25 | +24.9% | 419.29M | +12.1% | 10 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 3, 2026 | BTIG | Maintained | Buy | Buy |
| Jun 25, 2026 | Roth Capital | Initiated | — | Buy |
| May 13, 2026 | BTIG | Maintained | Buy | Buy |
| May 7, 2026 | Baird | Maintained | Outperform | Outperform |
| Apr 20, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| Feb 27, 2026 | Baird | Maintained | Outperform | Outperform |
| Jan 26, 2026 | Guggenheim | Maintained | Buy | Buy |
| Jan 12, 2026 | Lake Street | Maintained | Buy | Buy |
| Jan 5, 2026 | Guggenheim | Maintained | Buy | Buy |
| Dec 22, 2025 | Canaccord Genuity | Maintained | Buy | Buy |
| Dec 12, 2025 | BTIG | Maintained | Buy | Buy |
| Nov 5, 2025 | BTIG | Maintained | Buy | Buy |
| Nov 4, 2025 | Baird | Maintained | Outperform | Outperform |
| Sep 9, 2025 | Canaccord Genuity | Maintained | Buy | Buy |
| May 21, 2025 | Scotiabank | Maintained | Sector Outperform | Sector Outperform |
| May 6, 2025 | Lake Street | Maintained | Buy | Buy |
| May 6, 2025 | Canaccord Genuity | Maintained | Buy | Buy |
| Feb 28, 2025 | Baird | Maintained | Outperform | Outperform |
| Jan 2, 2025 | Stephens & Co. | Reiterated | Overweight | Overweight |
| Nov 6, 2024 | Scotiabank | Maintained | Sector Outperform | Sector Outperform |
| Nov 5, 2024 | Lake Street | Maintained | Buy | Buy |
| Nov 5, 2024 | Keybanc | Maintained | Overweight | Overweight |
| Nov 5, 2024 | Baird | Maintained | Outperform | Outperform |
| Oct 29, 2024 | Canaccord Genuity | Maintained | Buy | Buy |
| Oct 14, 2024 | BTIG | Maintained | Buy | Buy |
| Aug 6, 2024 | Stephens & Co. | Reiterated | Overweight | Overweight |
| Aug 6, 2024 | Baird | Maintained | Outperform | Outperform |
| Jul 5, 2024 | Baird | Maintained | Outperform | Outperform |
| May 3, 2024 | Baird | Maintained | Outperform | Outperform |
| Mar 1, 2024 | Keybanc | Maintained | Overweight | Overweight |